Study Exclusion reasons Remarks Reference(s)
EMPHASIS-lung, 2017 randomized controlled trial The final analysis of EMPHASIS-lung did not show a differential effect on PFS for erlotinib versus docetaxel

Smit EF J Thorac Oncol 2017; 12:752-762-. 10.1016/j.jtho.2016.12.017

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons